The British National Health Service on Tuesday issued new guidance permanently prohibiting the prescription of puberty blockers for children for the purposes of gender transition.
“We have concluded that there is not enough evidence to support the safety or clinical effectiveness of puberty suppressing hormones to make the treatment routinely available at this time,” an NHS spokesperson said in a statement obtained by the Washington Examiner.
Puberty blockers, which are often included in treatment plans for gender transitions for children with gender dysphoria, will now only be available to minors who are participating in clinical trial research.
“Puberty suppressing hormones are not available as a routine commissioning treatment option for treatment of children and young people who have gender incongruence / gender dysphoria,” the NHS spokesperson said.
Fewer than 100 minors
Read more…
